In addition to these promising effects of sGC stimulators, research has also shown that in a stroke model under acute oxidative stress, sGC activity is decreased in mouse homogenates of the cortex and basal ganglia, most likely due to oxidation of Fe(II)sGC and subsequent heme loss16. The gene discussed is SGCB; the disease is Stroke.